These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10997340)

  • 1. CD39 modulates endothelial cell activation and apoptosis.
    Goepfert C; Imai M; Brouard S; Csizmadia E; Kaczmarek E; Robson SC
    Mol Med; 2000 Jul; 6(7):591-603. PubMed ID: 10997340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
    Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
    Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD39 modulates IL-1 release from activated endothelial cells.
    Imai M; Goepfert C; Kaczmarek E; Robson SC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):272-8. PubMed ID: 10733939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
    Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
    Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
    Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells.
    Imai M; Kaczmarek E; Koziak K; Sévigny J; Goepfert C; Guckelberger O; Csizmadia E; Schulte Am Esch J; Robson SC
    Biochemistry; 1999 Oct; 38(41):13473-9. PubMed ID: 10521254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries.
    Gangadharan SP; Imai M; Rhynhart KK; Sévigny J; Robson SC; Conte MS
    Surgery; 2001 Aug; 130(2):296-303. PubMed ID: 11490363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
    Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
    J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival.
    Imai M; Takigami K; Guckelberger O; Kaczmarek E; Csizmadia E; Bach FH; Robson SC
    Transplantation; 2000 Sep; 70(6):864-70. PubMed ID: 11014639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis.
    von Albertini M; Palmetshofer A; Kaczmarek E; Koziak K; Stroka D; Grey ST; Stuhlmeier KM; Robson SC
    Biochem Biophys Res Commun; 1998 Jul; 248(3):822-9. PubMed ID: 9704012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
    Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
    Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity.
    Schulte am Esch J; Sévigny J; Kaczmarek E; Siegel JB; Imai M; Koziak K; Beaudoin AR; Robson SC
    Biochemistry; 1999 Feb; 38(8):2248-58. PubMed ID: 10029517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes.
    Koziak K; Sévigny J; Robson SC; Siegel JB; Kaczmarek E
    Thromb Haemost; 1999 Nov; 82(5):1538-44. PubMed ID: 10595651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.
    Leal DB; Streher CA; Neu TN; Bittencourt FP; Leal CA; da Silva JE; Morsch VM; Schetinger MR
    Biochim Biophys Acta; 2005 Jan; 1721(1-3):9-15. PubMed ID: 15652174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Alyonycheva TN; Safier LB; Hajjar KA; Posnett DN; Schoenborn MA; Schooley KA; Gayle RB; Maliszewski CR
    J Clin Invest; 1997 Mar; 99(6):1351-60. PubMed ID: 9077545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
    Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
    Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
    Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
    Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39.
    Neshat S; deVries M; Barajas-Espinosa AR; Skeith L; Chisholm SP; Lomax AE
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G399-405. PubMed ID: 19074640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
    Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
    Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.
    Koziak K; Bojakowska M; Robson SC; Bojakowski K; Soin J; Csizmadia E; Religa P; Gaciong Z; Kaczmarek E
    J Thromb Haemost; 2008 Jul; 6(7):1191-7. PubMed ID: 18485080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.